The US FDA is ready to assess and potentially improve its drug development communication practices after similar efforts related to the application review process, another addition to a growing list of efforts to improve transparency.
The agency wants to hire Eastern Research Group (ERG), which has conducted several similar studies of FDA practices, to look...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?